Ally Bridge Group (NY) LLC Quant / Systematic

Location: New York, NY

CIK: 0001822947 · Show all filings

Period: Q3 2021 (← Previous) (Next →)

Filing Date: Nov 15, 2021

Total Value: $340M (100.0% shares, 0.0% debt)

Holdings (31)

NTRA NATERA INC 8.8%
Value $29.87M Shares 268,000 Est. Cost $92.26 Unrealized +24.2%
SPDR SER TR 7.4%
Value $25.14M Shares 200,000 Est. Cost Unrealized
RGEN REPLIGEN CORP 5.9%
Value $20.23M Shares 70,000 Est. Cost $181.94 Unrealized +41.0%
ARVN ARVINAS INC 5.1%
Value $17.26M Shares 210,000 Est. Cost $54.99 Unrealized +60.7%
MIRATI THERAPEUTICS INC 4.9%
Value $16.81M Shares 95,000 Est. Cost $161.53 Unrealized
NUVB NUVATION BIO INC 4.9%
Value $16.51M Shares 1,660,947 Est. Cost $11.18 Unrealized -18.9%
FATE FATE THERAPEUTICS INC 4.7%
Value $16M Shares 270,000 Est. Cost $63.35 Unrealized +23.8%
SYROS PHARMACEUTICALS INC 4.5%
Value $15.38M Shares 3,439,895 Est. Cost $9.89 Unrealized
VRDN VIRIDIAN THERAPEUTICS INC 4.4%
Value $14.89M Shares 904,978 Est. Cost $18.20 Unrealized -19.4%
GOSS GOSSAMER BIO INC 4.3%
Value $14.77M Shares 1,175,000 Est. Cost $8.67 Unrealized +6.2%
IDYA IDEAYA BIOSCIENCES INC 4.3%
Value $14.68M Shares 575,940 Est. Cost $20.80 Unrealized +12.3%
COGT COGENT BIOSCIENCES INC 4.0%
Value $13.65M Shares 1,622,591 Est. Cost $10.99 Unrealized -30.3%
IOVA IOVANCE BIOTHERAPEUTICS INC 3.0%
Value $10.04M Shares 406,986 Est. Cost $39.90 Unrealized -41.0%
SOMALOGIC INC 2.9%
Value $9.912M Shares 800,000 Est. Cost $12.39 Unrealized
APELLIS PHARMACEUTICALS INC 2.9%
Value $9.888M Shares 300,000 Est. Cost Unrealized
NAUT NAUTILUS BIOTECHNOLOGY INC 2.7%
Value $9.21M Shares 1,500,000 Est. Cost $10.83 Unrealized -26.4%
NANOSTRING TECHNOLOGIES INC 2.6%
Value $8.882M Shares 185,000 Est. Cost $64.79 Unrealized
NTLA INTELLIA THERAPEUTICS INC 2.6%
Value $8.72M Shares 65,000 Est. Cost $36.31 Unrealized +316.9%
MEDAVAIL HOLDINGS INC 2.5%
Value $8.529M Shares 2,920,780 Est. Cost $15.05 Unrealized
RPID RAPID MICRO BIOSYSTEMS INC 2.4%
Value $8.089M Shares 437,960 Est. Cost $20.66 Unrealized 0.0%
SGHT SIGHT SCIENCES INC 2.3%
Value $7.77M Shares 342,304 Est. Cost $32.87 Unrealized 0.0%
MGNX MACROGENICS INC 2.2%
Value $7.643M Shares 365,000 Est. Cost $25.69 Unrealized -6.3%
INVITAE CORP 1.7%
Value $5.683M Shares 199,900 Est. Cost $33.73 Unrealized
CYTEIR THERAPEUTICS INC 1.6%
Value $5.608M Shares 319,538 Est. Cost $21.40 Unrealized
AMYRIS INC 1.4%
Value $4.839M Shares 352,445 Est. Cost $13.73 Unrealized
LEAP THERAPEUTICS INC 1.4%
Value $4.812M Shares 1,200,000 Est. Cost $4.01 Unrealized
IVERIC BIO INC 1.2%
Value $4.06M Shares 250,000 Est. Cost $16.24 Unrealized
BERKELEY LTS INC 1.2%
Value $3.951M Shares 201,996 Est. Cost $19.56 Unrealized
ADICET BIO INC 1.0%
Value $3.332M Shares 425,000 Est. Cost $13.08 Unrealized
BOLT BIOTHERAPEUTICS INC 1.0%
Value $3.254M Shares 257,267 Est. Cost $27.64 Unrealized
VERVE THERAPEUTICS INC 0.2%
Value $705K Shares 15,000 Est. Cost $47.00 Unrealized